180
Participants
Start Date
November 6, 2023
Primary Completion Date
November 13, 2024
Study Completion Date
November 13, 2024
AK120
subcutaneous injection every 2 weeks
The First Affiliated Hospital of Anhui Medical University, Hefei
Air Force Medical Center, Beijing
China-Japan Friendship Hospital, Beijing
Peking University Third Hospital, Beijing
The Second Affiliated Hospital of Xiamen Medical College, Xiamen
Dongguan People's Hospital, Dongguan
Dermatology Hospital of Southern Medical University, Guangzhou
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou
Zhujiang Hospital of Southern Medical University, Guangzhou
Shenzhen People's Hospital, Shenzhen
The Second Hospital of Hebei Medical University, Shijiazhuang
People Hospital of Xingtai, Xingtai
Renmin Hospital of Wuhan University Hubei General Hospital, Wuhan
Affiliated Hospital of Nantong University, Nantong
Yancheng No.1 People's Hospital, Yancheng
The Second Affiliated Hospital of Nanchang University, Nanchang
General Hospital of Ningxia Medical University, Yinchuan
Qingdao Municipal Hospital, Qingdao
Baoji Central Hospital, Baoji
Second Hospital of Shanxi Medical University, Taiyuan
Taiyuan Central Hospital, Taiyuan
Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin
The First Affiliated Hospital,Zhejiang University School of Medicine, Hangzhou
Ningbo No.2 Hospital, Ningbo
The first affiliated Hospital of Wenzhou Medical University, Wenzhou
The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu
Lead Sponsor
Akeso
INDUSTRY